Past event: Highly Potent Active Pharmaceutical Ingredients Conference

HPAPI containment and facility design for successful exposure control

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along with the increase in associated toxicities, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety. The conference will encompass the critical topics including risk assessment, occupational toxicology, engineering controls for containment, facility design, and the impact of pharmaceutical manufacture on the environment.

Benefits of Attending

  • EARN how to ensure advanced therapeutic manufacturing is safe for workers and patients
  • INCREASE the e ectiveness of your engineering containment controls by improving harmony between the worker engineer and toxicologist to ensures cost-e ective design choices
  • UNCOVER the best practises & opportunities for pharmaceutical companies to work alongside CMOs to effectively and efficiently scale-up HPAPI manufacturing
  • REVIEW case studies on the implementation of risk-based hazard identification strategies from leading pharmaceutical companies including AstraZeneca, CSL Behring and Merck
  • DISCOVER future trends in containment and control technologies to future-proof your HPAPI manufacturing plant to maximise operator safety

Who should attend

Key job titles include:
  • Head of Occupational hygiene
  • Head of Industrial hygiene
  • Head of Containment
  • Head of Corporate Toxicology
  • Head of Validation
  • Director of Operation Quality
  • Director of EHS
  • Director of Drug Safety Evaluation
  • Industrial Engineer
  • Validation Expert
  • Manufacturing Specialist
  • QA Specialist/Manage
  • Scale-up Operations Manager

Featured Speakers

  • Andreas Schreiner, Global Network Validation Leader, Novartis
  • Anna Kulesza, Director Pharmaceutical Development, Clovis Oncology
  • Brian Edwards, Chair, CIEHF
  • Brian Schmidt, Global Lead - Occupational Hygiene, Takeda
  • Christophe Dehondt, Global Head of EHS and BCM, Novartis, Advanced Accelerator Applications
  • Justin Mason-Home, FRSC, Director/Owner, HPAPI Project Services Limited
  • Martin Hogan, Managing Director , Corporate Health Ireland
  • Olindo Lazzaro, Global Head, EHS by Design, CSL Behring
  • Richard Arnett, Manager, Industrial Hygiene, Pharmascience
  • Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
  • Rosie Russell, Head of Environmental Health and Safety, MeiraGTx
  • Thomas Adam, Head of GQA-Chemical APIs, Bayer AG, R&D, Pharmaceutical
  • Toral Mehta, Industrial Hygienist and Containment Expert, GSE - Global Safety & Environment EHS, MSD

Please fill in your name and email to receive the Conference Agenda of this event.


Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK

Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-24103